← back to search

Kristy Rose

Sydney Children’s Hospitals Network · AU
Area of research
Genetics · Cellular and Molecular Neuroscience
Research interest
Research interests include Neurogenetic and Muscular Disorders Research, Hereditary Neurological Disorders, Cerebral Palsy and Movement Disorders, and Muscle Physiology and Disorders.
h-index
27
citations
3,896
works
52
NIH funding
primary concept
Medicine
email

Recent publications

Performance of upper limb entry item to predict forced vital capacity in dysferlin-deficient limb girdle muscular dystrophy
Neuromuscular Disorders 2024cited by 1position: middledoi
FIREFISH parts 1 and 2: 4-year efficacy and safety of risdiplam in type 1 spinal muscular atrophy
Arquivos de Neuro-Psiquiatria 2024cited by 0position: middledoi
FIREFISH Parts 1 and 2: 36-month safety and efficacy of risdiplam in Type 1 spinal muscular atrophy (SMA) (P7-9.009)
Neurology 2023cited by 1position: middledoi
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial
The Lancet Neurology 2022cited by 103position: middledoi
Clinical practice guideline for the management of paediatric Charcot-Marie-Tooth disease
Journal of Neurology Neurosurgery & Psychiatry 2022cited by 42position: middledoi
Risdiplam in Type 1 Spinal Muscular Atrophy
New England Journal of Medicine 2021cited by 406position: middledoi
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls
New England Journal of Medicine 2021cited by 271position: middledoi
Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale
Annals of Neurology 2021cited by 35position: middledoi
Consensus Guidelines for Improving Quality of Assessment and Training for Neuromuscular Diseases
Frontiers in Genetics 2021cited by 12position: middledoi
Evaluator Training and Reliability for SMA Global Nusinersen Trials
Journal of Neuromuscular Diseases 2018cited by 55position: middledoi
Examining longitudinal functional changes in Dysferlinopathy: The JAIN Clinical Outcome Study (P5.429)
Neurology 2018cited by 0position: middledoi
Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care
Neuromuscular Disorders 2017cited by 1,030position: middledoi
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet 2017cited by 453position: middledoi
Reference values for developing responsive functional outcome measures across the lifespan
Neurology 2017cited by 131position: middledoi
Safety and efficacy of progressive resistance exercise for Charcot-Marie-Tooth disease in children: a randomised, double-blind, sham-controlled trial
The Lancet Child & Adolescent Health 2017cited by 53position: middledoi
Repeatability, consistency, and accuracy of hand‐held dynamometry with and without fixation for measuring ankle plantarflexion strength in healthy adolescents and adults
Muscle & Nerve 2017cited by 31position: lastdoi
Normative reference values for strength and flexibility of 1,000 children and adults
Neurology 2016cited by 243position: middledoi
1000 Norms Project: protocol of a cross-sectional study cataloging human variation
Physiotherapy 2015cited by 57position: middledoi
Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy
Journal of Molecular Medicine 2013cited by 81position: middledoi
Consensus Statement on Standard of Care for Congenital Myopathies
Journal of Child Neurology 2012cited by 190position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Joshua Burns · St. Jude Children's Research Hospital6 papers (2015–2022)Marnee J. McKay · The University of Sydney5 papers (2015–2017)Basil T. Darras · Boston Children's Hospital5 papers (2018–2024)Jacqueline Raymond · The University of Sydney4 papers (2015–2017)Giovanni Baranello · Great Ormond Street Hospital4 papers (2021–2024)Ksenija Gorni · Roche (Switzerland)4 papers (2021–2024)Eugenio Mercuri · Istituto delle Scienze Neurologiche di Bologna4 papers (2018–2024)Kathryn M. Refshauge · The University of Sydney4 papers (2015–2017)Laurent Servais · University of Oxford4 papers (2021–2024)Anna Mayhew · Newcastle University4 papers (2018–2024)Amy D. Sman · The University of Sydney4 papers (2015–2017)Muna El-Khairi · Roche (United Kingdom)4 papers (2021–2024)Jennifer Baldwin · The University of Sydney4 papers (2015–2017) · 3 papers (2021–2024)Elizabeth J. Nightingale · University of Newcastle Australia3 papers (2015–2017)Milena Simić · The University of Sydney3 papers (2015–2017)Riccardo Masson · Mayo Clinic in Arizona3 papers (2021–2024)Caleb Wegener · University of Michigan3 papers (2015–2017)Andrea Klein · University of Bern3 papers (2021–2024)Tina Duong · Palo Alto University3 papers (2018–2024)